Malignant Testicular Neoplasm — Trials

Malignant Testicular Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

177 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 43
Recruiting: 26
Ph III recruiting: 3
Growth YoY: —
Industry share: 2%
Top sponsor: University Health Network, Toronto
Termination share: 35.3%
Trials / 1,000 deaths: 80.1 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (23)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06702592	Virtual Testis Cancer Lay Support and Survivorship Aim 2(VITALSS)	not yet recruiting	N/A	360	UNC Lineberger Comprehensive Cancer CenterOTHER	1	Aug 18, 2026	clinicaltrials
NCT07699640	Minimally-invasive ICG-guided Retroperitoneal Sentinel Lymph Node Dissection in the Primary Staging of Testicular Cancer Versus Standard of Care(RAISN 2)	not yet recruiting	N/A	171	Heinrich-Heine University, DuesseldorfOTHER